FB
FBTU.LSE First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF
- USD
No recent price
- Total assets
- 8.18M
- Expense ratio
- 0.58%
- Dividend yield
- -
- 1-year return
- +42.10%
- Holdings
- 30
- Since
- 2020
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does FBTU.LSE invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (94.5%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (94.8%)
- Top 3 holdings: 12.4% of the fund
Asset allocation
- US stocks 94.5%
- Non-US stocks 4.7%
- Cash 0.1%
Top holdings
- Genmab AS 4.69%
- Regeneron Pharmaceuticals Inc 3.90%
- Exelixis Inc 3.85%
- Halozyme Therapeutics Inc 3.73%
- Veracyte Inc 3.55%
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF performance
Sharpe ratio 1.26- This year
- +31.93%
- 1 year
- +42.10%
- 3 years
- +26.25%
- 5 years
- +10.39%
Volatility 18.5% over 1 year and 16.8% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
FBTU.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF top holdings
36.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Genmab AS GMAB.US | Healthcare | United States | 4.69% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 3.90% |
| Exelixis Inc EXEL.US | Healthcare | United States | 3.85% |
| Halozyme Therapeutics Inc HALO.US | Healthcare | United States | 3.73% |
| Veracyte Inc VCYT.US | Healthcare | United States | 3.55% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 3.48% |
| Alkermes Plc ALKS.US | Healthcare | United States | 3.47% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.43% |
| Biogen Inc BIIB.US | Healthcare | United States | 3.43% |
| TG Therapeutics Inc TGTX.US | Healthcare | United States | 3.37% |
The 10 largest of 30 holdings.
FBTU.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
FBTU.LSE regional exposure
- North America94.8%
- Europe Developed5.0%
Share of the stocks in the fund.
Company size
Average market cap 19.7B- Big cap16.2%
- Medium cap28.4%
- Small cap39.9%
- Micro cap13.2%
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF fund profile
- Fund name
- First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF
- Ticker
- FBTU.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- May 27, 2020
- Trading currency
- USD
- Expense ratio
- 0.58%